Company: PCRX
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001104659-25-041219
Chunk: 21

Company: Pacira BioSciences, Inc.
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 21
---
 MAJORITY VOTING STANDARD IN UNCONTESTED ELECTIONS In March 2025, our board amended our Bylaws to adopt a majority voting standard for uncontested elections of directors to better align our governance provisions with industry standards and market practice. Our board has also implemented a Director Resignation Policy in our Corporate Governance Guidelines. Under the policy, any incumbent director nominee who receives a greater number of votes “WITHHOLD” than votes “FOR” his or her election in an uncontested election must promptly tender his or her resignation to the board following certification of the stockholder vote. Within 90 days following the certification of the vote, independent directors on the board who were not required to tender their resignations would evaluate any such tendered resignation in light of the best interests of the Company and its stockholders and determine whether to accept or reject the tendered resignation, or whether other action should be taken. If the independent directors determine not to accept the tendered resignation, we will publicly disclose (via a press release or an SEC filing) such determination and the factors considered by the independent directors in making such determination. If the board accepts a director’s resignation pursuant to this process, the Nominating, Governance and Sustainability Committee would recommend to the board and the board would thereafter determine whether to fill such vacancy or reduce the size of the board. Board Meeting Annual Schedule

Pacira BioSciences, Inc. 2025 Proxy Statement | 27

TABLE OF CONTENTS Corporate Governance and Board Matters Director Independence 8 out of 9 Directors are Independent Our board has determined that each of our directors, with the exception of Frank D. Lee, our chief executive officer, is an “independent director” as defined under the applicable Nasdaq rules and SEC rules and regulations.

Board Committees Our board has established an Audit Committee, a People & Compensation Committee, a Nominating, Governance and Sustainability Committee and a Science and Technology Committee. Each of these committees operates under a written charter that has been approved by our board. Each committee charter is available by clicking on the “Investors—Corporate Governance” section of our corporate website, located at www.pacira.com . The following table is a summary of our committee structure and members on each of our committees.

| ​                      | ​ | ​ | ​                   | ​ | ​ | Board Committees |   |   |                      |   |   |                                        |   |   |                       | ​ |
| Name                   | ​ | ​ | IndependentDirector | ​ | ​ |